Related Experiment Video

Updated: Aug 5, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome

Fabio Catalano1,2,3, Dejan Stevic4,5,6, Giacomo Zundo4,5,6

  • 1Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, 3015GE, The Netherlands. f.catalano@erasmusmc.nl.

EMBO Molecular Medicine
|July 29, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

Related Experiment Videos

Last Updated: Aug 5, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Articles linked to this work by shared authors, journal, and citation graph.

Impacting Rare Diseases Healthcare by Case-Based Telelearning: Description of the Dutch Pilot Metabolic Diseases ECHO.

JIMD reports·2026

Base Editing: Mechanisms and Therapeutic Applications.

Methods in molecular biology (Clifton, N.J.)·2026

The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.

Neurology. Genetics·2026

Refining MMA Screening in the Dutch Newborn Screening Program: Lessons from Vitamin B12 Deficiency and Genetic Cases.

International journal of neonatal screening·2026

Disease characteristics of SEPSECS deficiency: An international, retrospective, multicenter cohort study.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

PTEN-loss confers dependence on the guanylate synthesis enzyme IMPDH in T-cell acute lymphoblastic leukemia.

EMBO molecular medicine·2026

RMND1 dysfunction causes OXPHOS deficiency and alters mitoribosomal protein homeostasis in vivo.

EMBO molecular medicine·2026

Artificial intelligence in central nervous system autoimmune diseases: from clinical decision support to mechanistic discovery and translation.

EMBO molecular medicine·2026

FAP adipogenesis drives early spinal muscle loss in dysferlinopathy and reveals a therapeutic target.

EMBO molecular medicine·2026

Extracellular RNA clearance by non-canonical cell-surface MDA5 protects against lung fibrosis.

EMBO molecular medicine·2026

FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.

EMBO molecular medicine·2026

NTDB: a curated database of natural transformation machinery and regulatory genes in prokaryotes.

Nucleic acids research·2026

Thymoquinone-Loaded Hexosomal Nanoparticles Attenuate Neuroinflammation and Improve Cognitive Function in an Alzheimer's Disease Mouse Model.

International journal of nanomedicine·2026

Engineered Chitosan Nanoparticle Platform Enables Controlled Ibuprofen Delivery and Coordinated Neuroimmune Regulation in a Human Microphysiological Model.

ACS applied bio materials·2026

Snail-shRNA in AAV9 inhibited EMT and pulmonary fibrosis in silica-instilled mice.

Toxicology letters·2026

3D-bioprinted dual-factor nerve conduits promote neurovascular co-regeneration via activation of the PI3K/AKT and MAPK/ERK pathways.

Biomaterials·2026

In situ delivery of cannabidiol-loaded GelMA sponge attenuates cerebral edema and neuroinflammation in traumatic brain injury.

Materials today. Bio·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us